Medtronic Announces Final Results of MiniMed Split-Off Exchange Offer
Medtronic plc
Subscribe to track MDT
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Medtronic plc ($MDT) has announced the final results of its exchange offer to split off MiniMed Group, Inc. ($MMED).
• Exchange Ratio & Structure: Exchanged all remaining 252,813,348 shares of MiniMed common stock for 55,032,401 Medtronic ordinary shares. • Oversubscription: 297,521,390 Medtronic ordinary shares were tendered against 55,032,401 accepted. • Proration Factor: 18.289133% for non-odd-lot tenders (757,890 odd-lot shares accepted in full). • Impact: Medtronic will no longer hold any equity stake in MiniMed, effectively retiring ~55.0M Medtronic ordinary shares.
Comprehensive Analysis
Executive Summary
On October 14, 2026, Medtronic plc (NYSE: MDT) filed Form 425 announcing the final results of its exchange offer regarding the separation of MiniMed Group, Inc. (Nasdaq: MMED). The exchange offer expired at midnight on October 9, 2026, and was heavily oversubscribed. Following completion, Medtronic fully divested its remaining interest in MiniMed.
Transaction & Exchange Details
- MiniMed Common Stock Exchanged: 252,813,348 shares (100% of Medtronic's remaining stake).
- Medtronic Ordinary Shares Accepted: 55,032,401 shares.
- Total Medtronic Shares Validly Tendered: 297,521,390 shares.
- Proration Terms:
- Shares Subject to Proration: 296,763,500 shares.
- Proration Factor: 18.289133%.
- Odd-Lot Shares (under 100 shares): 757,890 shares accepted in full without proration.
- Unaccepted Shares: Ordinary shares tendered but not accepted will be returned promptly in book-entry form.
- Fractional Shares: Cash delivered in lieu of fractional MiniMed shares following open-market aggregation and sale.
Strategic and Financial Impact
- Share Count Reduction: By accepting 55,032,401 Medtronic ordinary shares in exchange for its MiniMed equity, Medtronic substantially shrinks its outstanding share base, providing an accretive effect on EPS.
- Clean Separation: Medtronic retains zero equity ownership in MiniMed post-transaction, completing the spin-off/split-off process and establishing MiniMed as an independent publicly traded entity (Nasdaq: MMED).
- Dealer Managers: Goldman Sachs & Co. LLC and BofA Securities, Inc.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.